Tiago Fauth analyst WELLS FARGO

Currently out of the existing stock ratings of Tiago Fauth, 103 are a BUY (71.03%), 37 are a HOLD (25.52%), 5 are a SELL (3.45%).

Tiago Fauth

Work Performance Price Targets & Ratings Chart

Analyst Tiago Fauth, currently employed at WELLS FARGO, carries an average stock price target met ratio of 42.45% that have a potential upside of 21.08% achieved within 113 days. Previously, Tiago Fauth worked at CREDIT SUISSE.

Tiago Fauth’s has documented 289 price targets and ratings displayed on 29 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on UTHR, United Therapeutics at 20-Aug-2024.

Wall Street Analyst Tiago Fauth

Analyst best performing recommendations are on HGEN (HUMANIGEN).
The best stock recommendation documented was for HGEN (HUMANIGEN) at 7/13/2022. The price target of $0.5 was fulfilled within 2 days with a profit of $0.11 (18.03%) receiving and performance score of 90.16.

Average potential price target upside

ABCL Abcellera Biologics  APLS Apellis Pharmaceuticals ASND Ascendis Pharma AS BCAB Bioatla  IFRX InflaRx N.V. IMVT Immunovant  KURA Kura Oncology ME 23Andme Holding Co UTHR United Therapeutics ALXO Alx Oncology Holdings  ABSI Absci Corp AMGN Amgen ARGX argenx NV ADR ARNA Arena Pharmaceuticals BMRN Biomarin Pharmaceutical HGEN Humanigen ICPT Intercept Pharmaceuticals RARE Ultragenyx RXDX Prometheus Biosciences SPRB Spruce Biosciences  EDIT Editas Medicine VTYX Ventyx Biosciences FMTX Forma Therapeutics Holdings GLTO Galecto  ISEE IVERIC bio PYXS Pyxis Oncology VECT VectivBio Holding AG VRDN Viridian Therapeutics ALNY Alnylam Pharmaceuticals

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

2 months 16 days ago
(20-Aug-2024)

0/2 (0%)

$6.55 (120.18%)

Buy

$5

$2.27 (83.15%)

$7

3 months 25 days ago
(11-Jul-2024)

0/4 (0%)

$1.87 (59.74%)

Buy

$22

$19.27 (705.86%)

$32

1 years 2 days ago
(03-Nov-2023)

0/3 (0%)

$17.3 (368.09%)

Buy

$24

$21.27 (779.12%)

$30

1 years 3 months 1 days ago
(04-Aug-2023)

0/2 (0%)

$17.96 (297.35%)

Buy

$28

$25.27 (925.64%)

$34

1 years 6 months ago
(05-May-2023)

1/6 (16.67%)

$22.01 (367.45%)

24

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Tiago Fauth is most bullish on?

Potential upside of $24.01 has been obtained for RARE (ULTRAGENYX)

Which stock is Tiago Fauth is most reserved on?

Potential downside of -$40.91 has been obtained for ALNY (ALNYLAM PHARMACEUTICALS)

What Year was the first public recommendation made by Tiago Fauth?

On 2017

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?